CELULARITY
Celularity is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified NK cells, genetically-modified NK cells, T cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.
CELULARITY
Industry:
Biotechnology Health Care Therapeutics Wellness
Founded:
2017-09-01
Address:
Florham Park, New Jersey, United States
Country:
United States
Website Url:
http://www.celularity.com
Total Employee:
101+
Status:
Active
Contact:
908-768-2170
Email Addresses:
[email protected]
Total Funding:
400 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics
Similar Organizations
ALX Oncology
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with superior immune cell therapies.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Passage Bio
Passage Bio is a fully integrated gene therapy company developing therapies for the treatment of monogenic central nervous system diseases.
Scout Bio
Scout Bi is a biotechnology company that provides veterinary, animal health, and gene therapy.
X4 Pharmaceuticals
X4 Pharmaceuticals a clinical-stage oncology company developing best-in-class oral small molecule CXCR4 antagonists for the treatment.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2018-08-31 | Caricord | Caricord acquired by Celularity | N/A |
Investors List
Sorrento Therapeutics
Sorrento Therapeutics investment in Post-IPO Equity - Celularity
Dragasac Limited
Dragasac Limited investment in Post-IPO Equity - Celularity
Starr Insurance Companies
Starr Insurance Companies investment in Post-IPO Equity - Celularity
Section 32
Section 32 investment in Venture Round - Celularity
Celgene
Celgene investment in Venture Round - Celularity
Heritage Group
Heritage Group investment in Venture Round - Celularity
Tony Robbins
Tony Robbins investment in Venture Round - Celularity
Bill Maris
Bill Maris investment in Venture Round - Celularity
United Therapeutics
United Therapeutics investment in Venture Round - Celularity
Human Longevity
Human Longevity investment in Venture Round - Celularity
Official Site Inspections
http://www.celularity.com Semrush global rank: 2.26 M Semrush visits lastest month: 8.43 K
- Host name: 141.193.213.11
- IP address: 141.193.213.11
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
